Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Search publicationsResearcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
High-Quality Genome Assembly and Transcriptomic Analysis Reveal Potential Pathways for Psilocybin Biosynthesis in Gymnopilus dilepisJournal of Fungi · 2026-10-28Psilocybin for anhedonia in unipolar and bipolar depression: A systematic review of clinical and preclinical evidence.Journal of psychiatric research · 2026-10-19Investigating molecular and hemodynamic effects of LSD in the human brain.Nature neuroscience · 2026-10-12PsilocybinJAMA · 2026-10-06U.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences.Rand health quarterly · 2026-09-29An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.The Journal of clinical psychiatry · 2026-09-21Exploratory safety, tolerability, and feasibility of psilocybin-assisted psychotherapy for adults with co-occurring treatment-resistant depression and cluster B personality disordersnpj Mental Health Research · 2026-09-16Psilocybin-associated microRNA changes in the pig brain: Establishing an nCounter pipeline for cross-species microRNA quantification.European journal of pharmacology · 2026-09-10Active placebo control interventions in pharmacological trials: a scoping review of the development process and a terminological analysis.Journal of clinical epidemiology · 2026-09-01Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases.Metabolic engineering · 2026-09-01A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Impact of Psilocybin on Motor Function in Healthy Participants: A Phase 1, Randomised, Triple-Blind, Dose-Finding Study.CNS drugs · 2026-08-07Serotonergic psychedelics induce distinct patterns of metabolic activity and covariance within biologically informed rat brain networksNature Communications · 2026-08-03Psilocybin for Fear of Cancer RecurrenceSupportive Care in Cancer · 2026-08-01Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant DepressionClinicalTrials.gov · 2026-07-30Psilocybin's effect on human brain synaptic plasticity.Translational psychiatry · 2026-07-15Psilocybin-Assisted Early Palliative Care for Demoralization and Chronic Pain: An Open-Label Pilot Study.medRxiv: the preprint server for health sciences · 2026-07-14Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology.British journal of pharmacology · 2026-07-01Recreational drug poisonings reported to six European poison centres from 2021 to 2024.Clinical toxicology (Philadelphia, Pa.) · 2026-07-01Psychedelics as a potential treatment for borderline personality disorder: A narrative review.Psychiatry research · 2026-07-01Study Protocol for “Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults”PLOS One · 2026-06-30Multi-metric evaluations of acute psychedelic effects on fMRI brain entropy.Nature communications · 2026-06-24Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)Neurology · 2026-06-09Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depressionJournal of Affective Disorders · 2026-06-01U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.Rand health quarterly · 2026-06-01Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-29Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman SpectroscopyJournal of Raman Spectroscopy · 2026-05-28Association Between Lifetime Hallucinogen Use and Valvular Heart Disease: Findings from the All of Us Research Program.Journal of psychoactive drugs · 2026-05-18Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.PsyArXiv · 2026-05-14Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.Journal of medical Internet research · 2026-04-27The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomesMental Wellness · 2026-04-21Case Report: Repeated low doses of psilocybin reduce perceived symptom severity but fail to restore cognitive flexibility in a case of severe obsessive-compulsive disorder: an observational case study of identical twinsFrontiers in Psychiatry · 2026-04-21Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe MushroomsScience Letters · 2026-04-17Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivitybioRxiv · 2026-04-13Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.MMWR. Morbidity and mortality weekly report · 2026-04-08An international mega-analysis of psychedelic drug effects on brain circuit function.Nature medicine · 2026-04-01Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-StigmaSubstance Use & Misuse · 2026-03-28The QUANTUM Trip Trial - Psilocybin-assisted Therapy for Reducing Alcohol Intake in Patients With Alcohol Use Disorder: A Randomized, Double-blinded, Placebo-controlled Clinical Trial.ClinicalTrials.gov · 2026-03-24Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-19The combination of exercise and psychedelics for the treatment of major depressive disorder.Discover mental health · 2026-03-07Multidimensional Ego-Dissolution Assessment (MEDA): Scale Development and Substance-Specific ComparisonsPsyArXiv · 2026-03-02Meaning and Psychedelics in Palliative Care: A Narrative Review.Journal of pain and symptom management · 2026-03-01Early response to psilocybin in adults with treatment-resistant depression as a predictor for antidepressant efficacyGeneral Hospital Psychiatry · 2026-03-01The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?Psychiatric Research and Clinical Practice · 2026-03-01Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies.Pharmaceuticals (Basel, Switzerland) · 2026-02-14Computational Analysis of Psilocybin Effects on Three-Choice Touchscreen Reversal Learning in Rats: A Pilot StudyPsychedelic Medicine · 2026-02-03Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-02-01Psychedelic experiences elicited by serotonergic psychedelics: Molecular mechanisms and functional connectivity changes in the brain.Neuroscience and biobehavioral reviews · 2026-02-01Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01Regarding "The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses".Translational psychiatry · 2026-01-31Psychedelics distinctly alter brain entropy and complexity compared to psychostimulantsmedRxiv · 2026-01-16Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.Journal of affective disorders · 2026-01-15Behavioral effects of psychedelic and non-psychedelic serotonin 2A receptor agonist drugs in pigsNeuroscience Applied · 2026-01-01Psilocybin Treatment for Refractory Depression: A Clinical ReviewDigital Commons - Gardner-Webb University (Gardner-Webb University) · 2026-01-01Mechanisms of psilocybin on the treatment of posttraumatic stress disorder.Journal of psychopharmacology (Oxford, England) · 2026-01-01Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study.Journal of addiction medicine · 2026-01-01Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety.General hospital psychiatry · 2026-01-01Psychedelic therapy and postpartum depression: priorities and prospects.Therapeutic advances in psychopharmacology · 2026-01-01A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy ParticipantsmedRxiv · 2025-12-23Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.Progress in neuro-psychopharmacology & biological psychiatry · 2025-12-20Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Journal of affective disorders · 2025-12-15Psychedelics for the Treatment of Substance Use DisordersSUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · 2025-12-01Three Cases of Depersonalization/Derealization Disorder Related to the Use of Classic PsychedelicsSUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · 2025-12-01Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging studyAlzheimer's & dementia: the journal of the Alzheimer's Association · 2025-12-01Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2025-12-01Persistent Altered States: Psychological Treatment of Psychedelic Adverse EffectsTidsskrift for Norsk psykologforening · 2025-11-30Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics.ACS chemical neuroscience · 2025-11-19Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.Journal of affective disorders · 2025-11-15Correction: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational psychiatry · 2025-11-06Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study.Acta neuropsychiatrica · 2025-11-04Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.Translational psychiatry · 2025-10-31Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial.Pilot and feasibility studies · 2025-10-28Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2025-10-01Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 cases.Nordic journal of psychiatry · 2025-10-01The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.Neuron · 2025-10-01Concomitant use of antidepressants and classic psychedelics: A scoping review.Journal of psychopharmacology (Oxford, England) · 2025-10-01Psychedelics Relax Priors and Reshape Orbitofrontal DynamicsbioRxiv · 2025-09-19Psilocybin biosynthesis enhancement through gene source optimization.Metabolic engineering · 2025-09-01Adverse reactions among psychedelic users: Norwegian validation of the Challenging Experience Questionnaire.Journal of psychiatric research · 2025-09-01Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.Journal of psychopharmacology (Oxford, England) · 2025-09-01229. PSILOCYBIN WITH PSYCHOTHERAPEUTIC SUPPORT FOR TREATMENT-RESISTANT DEPRESSION: A PILOT CLINICAL TRIALThe international journal of neuropsychopharmacology · 2025-08-01Pathway engineering for the biosynthesis of psychedelics.Current opinion in biotechnology · 2025-08-01Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.Asian journal of psychiatry · 2025-08-01Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-07-01The Rise of Psilocybin Use in the United States: A Multisource Observational Study.Annals of internal medicine · 2025-07-01Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Psychiatry research · 2025-07-01Molecular, haemodynamic and functional effects of LSD in the human brainmedRxiv · 2025-06-18Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.Scientific data · 2025-06-18The Selective Serotonin 5-HT Receptor Agonist ()-3-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)piperidine (LPH-5) Induces Persistent and Robust Antidepressant-Like Effects in Rodents.ACS pharmacology & translational science · 2025-06-13Mycelium Growth and Development of spp. Mother Cultures on Agar-Based Media.Journal of fungi (Basel, Switzerland) · 2025-06-13Psilocybin's acute and persistent brain effects: a precision imaging drug trial.Scientific data · 2025-06-05Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.Clinical pharmacology and therapeutics · 2025-06-01Neurochemical characterization of 5-HTR partial agonists with simultaneous PET-MRI.Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025-05-01188. Mapping Psilocybin Therapy: A Systematic Review of Therapeutic Frameworks, Adaptations, and Standardization Across Contemporary Clinical TrialsBiological Psychiatry · 2025-04-09Precision Functional Mapping of Psilocybin’s Acute and Persistent Brain EffectsBiological Psychiatry · 2025-04-09194. Improving Workplace and Psychosocial Function in Treatment-Resistant Depression: Exploratory Outcomes From an Open-Label Feasibility Trial of Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-09187. Changes in Symptoms of Anhedonia With Psilocybin-Assisted Psychotherapy: A Secondary Analysis of a Randomized Clinical Trial for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-09186. Assessing Cognitive Outcomes in Treatment-Resistant Depression Following Psilocybin-Assisted PsychotherapyBiological Psychiatry · 2025-04-0913. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-09323. Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study ParticipationBiological Psychiatry · 2025-04-09Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-04-01A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-04-01A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-04-01Psilocybin Dispensaries and Online Health Claims in Canada.JAMA network open · 2025-04-01Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDi.Journal of the American Society for Mass Spectrometry · 2025-03-05Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression.The British journal of psychiatry: the journal of mental science · 2025-03-01Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01A qualitative analysis of the psychedelic mushroom come-up and come-down.Npj mental health research · 2025-02-07Single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - A first-in-kind open-label pilot study.Journal of affective disorders · 2025-01-15Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.Progress in neuro-psychopharmacology & biological psychiatry · 2025-01-10Validation of the Danish Translation of the Revised Mystical Experience Questionnaire (MEQ30) and Possible Impact of Setting, Dose and Intention.Journal of psychoactive drugs · 2025-01-01Molecular brain imaging of psychedelic action.International review of neurobiology · 2025-01-01Brain changes associated with depression treatment: a meta-analysis.NeuroImage. Clinical · 2025-01-01Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial.PloS one · 2025-01-01Contextual and experiential aspects of the psychedelic experience predicting improvement in subjective wellbeing: results from a Norwegian internet convenience sample.Frontiers in pharmacology · 2025-01-01Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Therapeutic advances in psychopharmacology · 2025-01-01Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial.Therapeutic advances in psychopharmacology · 2025-01-01Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.Therapeutic advances in psychopharmacology · 2025-01-01The Neurobiological Effect of 5-HT2AR ModulationClinicalTrials.gov · 2024-12-16Neuroimaging of Serotonergic and Psychedelic Agonist Drug Challenges in Non-Human PrimatesProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-11-25Therapeutic Potential of Psychedelic Compounds for Substance Use Disorders.Pharmaceuticals (Basel, Switzerland) · 2024-11-05Therapeutic Potential of Psychedelic Compounds for Substance Use DisordersPreprints.org · 2024-10-17Psilocybin-assisted psychotherapy as an ‘anti-distressant’ with multidimensional propertiesNature Mental Health · 2024-10-14Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.British journal of pharmacology · 2024-10-01Altered states of consciousness in Danish healthy volunteers and recreational users of psilocybin and the possible impact of setting and intention: Danish validation of the five-dimensional altered states of consciousness questionnaire.Journal of psychopharmacology (Oxford, England) · 2024-10-01Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humansmedRxiv · 2024-09-22Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label StudyResearch Square · 2024-08-23Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.BMJ (Clinical research ed.) · 2024-08-21Acute Effects of Psilocybin and Salvinorin-A on Functional ConnectivityProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-08-13Psychedelic-assisted psychotherapy: where is the psychotherapy research?Psychopharmacology · 2024-08-01Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.Journal of psychiatric research · 2024-08-01Psilocybin desynchronizes the human brain.Nature · 2024-08-01Acute Effects of Hallucinogens on Functional Connectivity: Psilocybin and Salvinorin-A.ACS chemical neuroscience · 2024-07-17Assessment of psychedelic--induced states: Norwegian translation and adaptation of the revised Mystical Experience Questionnaire (MEQ-30)Journal of Psychedelic Studies · 2024-07-12Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility StudyClinicalTrials.gov · 2024-07-12Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression.Trials · 2024-07-03Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.Journal of affective disorders · 2024-06-15Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT Receptor Agonists.Journal of medicinal chemistry · 2024-05-09The selective 5-HT2A receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodentsbioRxiv · 2024-04-22A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Journal of affective disorders · 2024-04-01Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s JourneyResearch Square · 2024-02-23Prefrontal Electrophysiological Biomarkers and Mechanism-Based Drug Effects in a Rat Model of Alcohol AddictionResearch Square · 2024-02-22Will Psilocybin-Assisted Therapy Reduce the Incidence of Medical Assistance in Dying?Journal of palliative medicine · 2024-02-01MicroRNAs underlying the antidepressant effect of psilocybin - Establishing an nCounter pipeline for microRNA-quantification in the pig brainResearch Square · 2024-01-12Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2024-01-01Psychedelics: The New Kid on the BlockAnnals of Indian Psychiatry · 2024-01-01Pharmacological characterization of psilocin affinity towards different 5-HT receptors and receptor regulation after psilocybin administration in pigsNeuroscience Applied · 2024-01-01Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.Journal of psychopharmacology (Oxford, England) · 2024-01-01CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals.Neuroscience applied · 2024-01-01Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.Neuroscience applied · 2024-01-01Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.Neuroscience applied · 2024-01-01Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants.Psychiatric research and clinical practice · 2024-01-01The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.Frontiers in psychiatry · 2024-01-01Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Journal of psychoactive drugs · 2024-01-01Evaluation of TrpM and PsiD substrate promiscuity reveals new biocatalytic capabilities.Biotechnology progress · 2024-01-01Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybinMedical Writing · 2023-12-11A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond.Biotechnology advances · 2023-12-01Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2023-11-01Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.Neuroscience and biobehavioral reviews · 2023-11-01Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.Psychiatry research · 2023-11-01Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushroomsbioRxiv · 2023-10-23Psychedelics for Patients With Cancer: A Comprehensive Literature Review.The Annals of pharmacotherapy · 2023-09-01Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.Molecular psychiatry · 2023-09-01Psilocybin desynchronizes brain networks.medRxiv: the preprint server for health sciences · 2023-08-24Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial.BJPsych open · 2023-07-25A proof-of concept randomized controlled trial to show that the antidepressant effect of psilocybin does not require a psychedelic experience: study protocolEuropean psychiatry: the journal of the Association of European Psychiatrists · 2023-07-19Navigating the chaos of psychedelic fMRI brain-entropy via multi-metric evaluations of acute psilocybin effectsmedRxiv · 2023-07-03The molecular basis of the antidepressant action of the magic mushroom extract, psilocinBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2023-07-01Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.Journal of psychopharmacology (Oxford, England) · 2023-07-01In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.Science advances · 2023-06-16Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.Nature neuroscience · 2023-06-01Novel psilocin prodrugs with altered pharmacological properties as candidate therapies for treatment-resistant anxiety disordersbioRxiv · 2023-05-18The use of classic psychedelics among adults: a Danish online survey study.Nordic journal of psychiatry · 2023-05-01Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.The American journal of psychiatry · 2023-05-01High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybinbioRxiv · 2023-04-14118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-10509. Meta-Analysis of Functional Neuroimaging Studies of the Effects of Serotonergic Psychedelics on Neural ActivityBiological Psychiatry · 2023-04-09Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairmentMedical Hypotheses · 2023-04-05To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.Experimental and clinical psychopharmacology · 2023-04-01The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging StudiesEuropean Psychiatry · 2023-02-28Effect of psilocybin on decision-making and motivation in the healthy rat.Behavioural brain research · 2023-02-25Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognitionbioRxiv · 2023-02-16The therapeutic potential of psychedelics: the European regulatory perspectiveThe Lancet · 2023-02-10Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation.Comprehensive psychoneuroendocrinology · 2023-02-01Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekstPsyArXiv · 2023-01-04Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekstPsyArXiv · 2023-01-04Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labellingNeuroscience Applied · 2023-01-01Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controlsNeuroscience Applied · 2023-01-01A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteersNeuroscience Applied · 2023-01-01Sustained effects of single doses of classical psychedelics in humans.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-01-01The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2023-01-01Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.Frontiers in psychiatry · 2023-01-01Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.Contemporary clinical trials · 2022-12-01Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effectsNeuroImage · 2022-12-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03